Serum ferritin levels and the development of metabolic syndrome and its components: a 6.5-year follow-up study.

Päivi Hämäläinen, Juha Saltevo, Hannu Kautiainen, Pekka Mäntyselkä, Mauno Vanhala
Author Information
  1. Päivi Hämäläinen: Department of Internal Medicine, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland.
  2. Juha Saltevo: Department of Internal Medicine, Central Finland Central Hospital, Jyväskylä, Finland.
  3. Hannu Kautiainen: Unit of Family Practice, Central Finland Central Hospital, Jyväskylä, Finland ; Unit of Primary Health Care, University of Eastern Finland, Kuopio, Finland.
  4. Pekka Mäntyselkä: Unit of Primary Health Care, University of Eastern Finland, Kuopio, Finland ; Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland.
  5. Mauno Vanhala: Unit of Family Practice, Central Finland Central Hospital, Jyväskylä, Finland ; Unit of Primary Health Care, University of Eastern Finland, Kuopio, Finland ; Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland.

Abstract

BACKGROUND: The aim of this study was to investigate the relationship between changes in serum ferritin concentrations and the development of metabolic syndrome (MetS) and its components over a 6.5 year follow-up period in Finnish adults.
METHODS: Adults born in Pieksämäki, Finland, in 1942, 1947, 1952, 1957, and 1962 (n = 1294) were invited to health checkups between 1997 and 1998 and 2003 and 2004. All of the required variables for both checkups were available from 691 (53%) subjects (289 men and 402 women). MetS was defined by the National Cholesterol Education Program criteria.
RESULTS: During the 6.5-year follow-up period, 122 (18%) subjects developed incident cases of MetS. Increases in serum ferritin levels were significantly higher in both women and men with incident MetS compared with women and men without MetS (p = 0.04, p = 0.03). Also, serum ferritin levels increased significantly less in women in whom the criteria for MetS resolved during the follow-up period (p = 0.01). Increases in serum ferritin levels were significantly lower in women in whom the glucose criterion for MetS resolved, and higher in women for whom the waist criterion developed (p = 0.01 and p <0.001, respectively). Serum ferritin levels decreased significantly more in men in whom the triglyceride criterion for MetS resolved during the follow-up period (p = 0.01). There was a clear and significant correlation between change in serum ferritin level and change in waist circumference both in men and women (p <0.001, p <0.01). In addition, correlations between change in serum ferritin level and change in plasma triglyceride as well as glucose levels were strongly positive in men (p <0.001). There was negative correlation between change in serum ferritin and plasma high density cholesterol level both in men and women.
CONCLUSIONS: Increases in serum ferritin over a 6,5 year period are associated with development of MetS in both men and women. Whereas, lower increases in serum ferritin over the same timeframe are associated with resolution of hypertriglyceridemia in men and hyperglycemia in women. Increases in waist circumference was positively correlated with increases in serum ferritin in both men and women.

Keywords

References

  1. Metabolism. 2011 Oct;60(10):1416-24 [PMID: 21489582]
  2. Gastroenterology. 2006 Sep;131(3):788-96 [PMID: 16952548]
  3. Eur J Endocrinol. 2013 Jul 13;169(2):247-53 [PMID: 23715774]
  4. Blood. 2011 Apr 28;117(17):4425-33 [PMID: 21346250]
  5. Blood. 2003 May 1;101(9):3359-64 [PMID: 12521995]
  6. Clin Endocrinol (Oxf). 2003 Mar;58(3):380-5 [PMID: 12608945]
  7. Int J Obes Relat Metab Disord. 2001 May;25(5):628-38 [PMID: 11360144]
  8. Diabetes Obes Metab. 2009 May;11(5):472-9 [PMID: 19207293]
  9. J Clin Endocrinol Metab. 2008 Dec;93(12):4690-6 [PMID: 18796516]
  10. Diabetologia. 2012 Oct;55(10):2613-2621 [PMID: 22752055]
  11. J Investig Med. 2004 Jan;52(1):19-23 [PMID: 14989366]
  12. Clin Chim Acta. 2012 Mar 22;413(5-6):636-41 [PMID: 22212623]
  13. Nature. 2006 Dec 14;444(7121):881-7 [PMID: 17167477]
  14. Circulation. 2009 Oct 20;120(16):1640-5 [PMID: 19805654]
  15. Int J Obes Relat Metab Disord. 2000 Nov;24 Suppl 4:S23-7 [PMID: 11126235]
  16. Diabetes Metab Res Rev. 2011 Sep;27(6):597-603 [PMID: 21538776]
  17. Int J Hematol. 1996 Feb;63(2):103-35 [PMID: 8867722]
  18. PLoS One. 2012;7(10):e48250 [PMID: 23144745]
  19. Free Radic Biol Med. 2005 Nov 15;39(10):1385-98 [PMID: 16257648]
  20. Toxicol Lett. 1995 Dec;82-83:969-74 [PMID: 8597169]
  21. Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12587-94 [PMID: 17640906]
  22. Diabetes Care. 2005 Aug;28(8):2061-3 [PMID: 16043762]
  23. Am J Med Sci. 2003 Jun;325(6):332-9 [PMID: 12811229]
  24. Eur J Endocrinol. 2006 Feb;154(2):333-40 [PMID: 16452549]
  25. Lancet. 2000 Jun 24;355(9222):2181-2 [PMID: 10881887]
  26. JAMA. 2004 Feb 11;291(6):711-7 [PMID: 14871914]
  27. Diabetes Care. 1997 Mar;20(3):426-8 [PMID: 9051399]
  28. Diabetologia. 2007 May;50(5):949-56 [PMID: 17333112]
  29. Diabetes Care. 2004 Oct;27(10):2422-8 [PMID: 15451911]
  30. Diabetes Care. 2012 Dec;35(12):2521-6 [PMID: 22933431]
  31. Diabetol Metab Syndr. 2010 Sep 20;2:58 [PMID: 20854668]
  32. Diabetes Care. 2006 Sep;29(9):2090-4 [PMID: 16936158]
  33. Lancet. 2005 Apr 16-22;365(9468):1415-28 [PMID: 15836891]
  34. Cardiovasc Diabetol. 2012 Sep 27;11:116 [PMID: 23016887]
  35. Eur J Clin Invest. 2011 May;41(5):479-86 [PMID: 21128934]
  36. BMC Med. 2012 May 30;10:54 [PMID: 22647517]
  37. Clin Endocrinol (Oxf). 2012 Aug;77(2):233-40 [PMID: 21977991]
  38. Annu Rev Med. 2005;56:45-62 [PMID: 15660501]
  39. PLoS One. 2010 Apr 09;5(4):e10100 [PMID: 20396381]

Word Cloud

Created with Highcharts 10.0.0ferritinwomenserummenMetSp=levelsfollow-upperiod0change6Increasessignificantly01<0developmentsyndromeresolvedcriterionwaist001levelstudymetabolic5 yearcheckupssubjectscriteria5-yeardevelopedincidenthigherlowerglucoseSerumtriglyceridecorrelationcircumferenceplasmaassociatedincreasesBACKGROUND:aiminvestigaterelationshipchangesconcentrationscomponentsFinnishadultsMETHODS:AdultsbornPieksämäkiFinland19421947195219571962n1294invitedhealth1997199820032004requiredvariablesavailable69153%289402definedNationalCholesterolEducationProgramRESULTS:12218%casescomparedwithout0403AlsoincreasedlessrespectivelydecreasedclearsignificantadditioncorrelationswellstronglypositivenegativehighdensitycholesterolCONCLUSIONS:Whereastimeframeresolutionhypertriglyceridemiahyperglycemiapositivelycorrelatedcomponents:FerritinMetabolicObesity

Similar Articles

Cited By